RxDoctor Payments Data

Kirk Hutton, MD

Orthopaedic Surgery · Omaha, NENPI 1861406837

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (48.4%), travel and lodging and education — rather than concentrated in one kind of arrangement. 11 manufacturers reported payments, led by Depuy Synthes Products, Inc. at 48.6% of the total. Reporting peaked in 2019 at $10,256 and has fallen 96.7% since, to $339 in 2025.

$14,507in general payments, 2019–2025

Across 80 payments — averaging $181.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Depuy Synthes Products, Inc.$7K
  • Arthrex$3K
  • Conetic Solutions, Inc.$2K
  • Johnson & Johnson$981
  • RSW Medical Company, Inc.$402
  • Stryker$394
  • plus $455 from 5 others

What the payments were for

  • Consulting fees$7,02048%
  • Travel & lodging$2,92220%
  • Food & beverage$2,28016%
  • Education$2,28516%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$14,507 in reported general payments places this provider in the 85th percentile of 155 orthopaedic surgery providers in Nebraska.

See all orthopaedic surgery providers in Nebraska

Medicare billing

Part B allowed, 2024
$222,210
Medicare patients
424
Services billed
1,759

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav14$447
Meloxicam82$176
Celecoxib14$153
Diclofenac Sodium12$78
Amoxicillin58$76
Prednisone34$68
Ibuprofen11$26

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Omaha

See the full list for Nebraska

Where these figures come from

Is this you, or does something look wrong? →